Combination treatment with doxorubicin and gamitrinib synergistically augments anticancer activity through enhanced activation of Bim

BackgroundA common approach to cancer therapy in clinical practice is the combination of several drugs to boost the anticancer activity of available drugs while suppressing their unwanted side effects. In this regard, we examined the efficacy of combination treatment with the widely-used genotoxic drug doxorubicin and the mitochondriotoxic Hsp90 inhibitor gamitrinib to exploit disparate stress signaling pathways for cancer therapy.MethodsThe cytotoxicity of the drugs as single agents or in combination against several cancer cell types was analyzed by MTT assay and the synergism of the drug combination was evaluated by calculating the combination index. To understand the molecular mechanism of the drug synergism, stress signaling pathways were analyzed after drug combination. Two xenograft models with breast and prostate cancer cells were used to evaluate anticancer activity of the drug combination in vivo. Cardiotoxicity was assessed by tissue histology and serum creatine phosphokinase concentration.ResultsGamitrinib sensitized various human cancer cells to doxorubicin treatment, and combination treatment with the two drugs synergistically increased apoptosis. The cytotoxicity of the drug combination involved activation and mitochondrial accumulation of the proapoptotic Bcl-2 family member Bim. Activation of Bim was associated with increased expression of the proapoptotic transcription factor C/EBP-homologous protein and enhanced activation of the stress kinase c-Jun N-terminal kinase. Combined drug treatment with doxorubicin and gamitrinib dramatically reduced in vivo tumor growth in prostate and breast xenograft models without increasing cardiotoxicity.ConclusionsThe drug combination showed synergistic anticancer activities toward various cancer cells without aggravating the cardiotoxic side effects of doxorubicin, suggesting that the full therapeutic potential of doxorubicin can be unleashed through combination with gamitrinib.

• Publication year

  2014

• Venue

  BMC Cancer

• Publication date

  2014-06-13

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1186/1471-2407-14-431PMID 24927938PMCID 4072609
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1

  2013cited by this paper
• Metabolic stress regulates cytoskeletal dynamics and metastasis of cancer cells.

  2013cited by this paper
• LANDSCAPE OF THE MITOCHONDRIAL Hsp90 METABOLOME IN TUMORS

  2013cited by this paper
• Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis

  2013cited by this paper
• Control of tumor bioenergetics and survival stress signaling by mitochondrial HSP90s.

  2012cited by this paper
• FOXO3-induced reactive oxygen species are regulated by BCL2L11 (Bim) and SESN3

  2012cited by this paper
• The Mitochondrial Chaperone TRAP1 Promotes Neoplastic Growth by Inhibiting Succinate Dehydrogenase

  2012cited by this paper
• Combinatorial drug therapy for cancer in the post-genomic era

  2012cited by this paper
• Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease

  2011cited by this paper
• Exploiting the mitochondrial unfolded protein response for cancer therapy in mice and human cells.

  2011cited by this paper
• Targeting the dynamic HSP90 complex in cancer

  2010cited by this paper
• HSP90 at the hub of protein homeostasis: emerging mechanistic insights

  2010cited by this paper
• The Expression Patterns of ER, PR, HER2, CK5/6, EGFR, Ki-67 and AR by Immunohistochemical Analysis in Breast Cancer Cell Lines

  2010influential reference
• Different contribution of BH3-only proteins and caspases to doxorubicin-induced apoptosis in p53-deficient leukemia cells.

  2010cited by this paper
• Preclinical Characterization of Mitochondria-Targeted Small Molecule Hsp90 Inhibitors, Gamitrinibs, in Advanced Prostate Cancer

  2010cited by this paper
• Cytoprotective mitochondrial chaperone TRAP-1 as a novel molecular target in localized and metastatic prostate cancer.

  2010cited by this paper
• Drug combination studies and their synergy quantification using the Chou-Talalay method.

  2010cited by this paper
• COMPARTMENTALIZED CANCER DRUG DISCOVERY TARGETING MITOCHONDRIAL Hsp90 CHAPERONES

  2009cited by this paper
• Combinatorial drug design targeting multiple cancer signaling networks controlled by mitochondrial Hsp90.

  2009cited by this paper
• DR5-mediated DISC controls caspase-8 cleavage and initiation of apoptosis in human glioblastomas

  2009cited by this paper
• DNA Topoisomerases

  2009cited by this paper
• Multisite phosphorylation regulates Bim stability and apoptotic activity.

  2008cited by this paper
• The BCL-2 protein family: opposing activities that mediate cell death

  2008cited by this paper
• Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.

  2008cited by this paper
• Mitochondrial membrane permeabilization in cell death.

  2007cited by this paper
• ER stress triggers apoptosis by activating BH3-only protein Bim.

  2007cited by this paper
• Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network.

  2007cited by this paper
• Doxorubicin prevents endoplasmic reticulum stress-induced apoptosis.

  2006cited by this paper
• Doxorubicin requires the sequential activation of caspase-2, protein kinase Cdelta, and c-Jun NH2-terminal kinase to induce apoptosis.

  2005cited by this paper
• Regulatory phosphorylation of Bim: sorting out the ERK from the JNK

  2005cited by this paper
• Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity

  2004cited by this paper
• CHOP Is Involved in Endoplasmic Reticulum Stress-induced Apoptosis by Enhancing DR5 Expression in Human Carcinoma Cells*

  2004cited by this paper
• C/EBP family transcription factors are degraded by the proteasome but stabilized by forming dimer

  2003cited by this paper
• BMC Cancer

  2003cited by this paper
• JNK-mediated BIM phosphorylation potentiates BAX-dependent apoptosis.

  2003cited by this paper
• JNK phosphorylation of Bim-related members of the Bcl2 family induces Bax-dependent apoptosis

  2003cited by this paper
• SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase

  2001cited by this paper
• The hsp90-related Protein TRAP1 Is a Mitochondrial Protein with Distinct Functional Properties*

  2000cited by this paper
• Doxorubicin-Induced Cardiomyopathy

  2000cited by this paper
• A new human prostate carcinoma cell line, 22Rv1

  1999cited by this paper
• Doxorubicin-induced cardiomyopathy.

  1998cited by this paper
• Overexpression of metallothionein in the heart of transgenic mice suppresses doxorubicin cardiotoxicity.

  1997cited by this paper
• DNA topoisomerases.

  1996cited by this paper
• Risk factors for doxorubicin-induced congestive heart failure.

  1979cited by this paper
• A clinicopathologic analysis of adriamycin cardiotoxicity

  1973cited by this paper

• Buthionine sulfoximine acts synergistically with doxorubicin as a sensitizer molecule on different tumor cell lines

  2025cites this paper
• Overcoming cancer drug resistance through small-molecule targeting of HSP90 and HSP70

  2025cites this paper
• TRAP1 inhibits KANSL3 acetylation to alleviate mitochondrial dysfunction by promoting mitophagy in cardiomyocytes under diabetic conditions

  2025cites this paper
• TRAP1 promotes self-renewal and tumorigenicity of glioblastoma stem cells by inhibiting Notch1 ubiquitination.

  2025cites this paper
• Herbal formulations, Product Nkabinde and Gnidia sericocephala, exhibit potent in vitro activity against HIV-1 infection

  2025cites this paper
• Smac Mimetic BV6 Increases the Sensitivity of Cancer Cells to Doxorubicin Through Suppression of Apoptosis Inhibitors

  2025cites this paper
• Emerging Research and Future Directions on Doxorubicin: A Snapshot

  2025cites this paper
• Synergistic anticancer effects of doxorubicin and metformin combination therapy: A systematic review

  2024cites this paper
• HuR inhibition overcomes cFLIP-mediated doxorubicin resistance in triple-negative breast cancer

  2024cites this paper
• Development of a Fluorescence Probe for High-Throughput Screening of Allosteric Inhibitors Targeting TRAP1.

  2024cites this paper
• Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro

  2024cites this paper
• Synthesis and investigation of cytotoxic effects of compounds derived from flurbiprofen

  2023cites this paper
• The development of cancers research based on mitochondrial heat shock protein 90

  2023cites this paper
• Novel N-Arylmethyl-aniline/chalcone hybrids as potential VEGFR inhibitors: synthesis, biological evaluations, and molecular dynamic simulations

  2023cites this paper
• Prion protein-dependent regulation of p53-MDM2 crosstalk during endoplasmic reticulum stress and doxorubicin treatments might be essential for cell fate in human breast cancer cell line, MCF-7.

  2023cites this paper
• Preparation and characterization of cetuximab-loaded egg serum albumin nanoparticles and their uses as a drug delivery system against Caco-2 colon cancer cells

  2023cites this paper
• Mitochondria Dysfunction-Mediated Molecular Subtypes and Gene Prognostic Index for Prostate Cancer Patients Undergoing Radical Prostatectomy or Radiotherapy

  2022cites this paper
• Structure, Function, and Inhibitors of the Mitochondrial Chaperone TRAP1.

  2022cites this paper
• Magneto-Fluorescent Mesoporous Nanocarriers for the Dual-Delivery of Ofloxacin and Doxorubicin to Tackle Opportunistic Bacterial Infections in Colorectal Cancer

  2022cites this paper
• Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance

  2022cites this paper
• Chemical Structures and Cell Death Inducing Activities of Constituents Isolated from Hibiscus tiliaceus

  2022cites this paper
• Combinatorial delivery of Ribociclib and green tea extract mediated nanostructured lipid carrier for oral delivery for the treatment of breast cancer synchronising in silico, in vitro, and in vivo studies

  2022cites this paper
• TRAP1 Chaperones the Metabolic Switch in Cancer

  2022cites this paper
• Triphenylphosphonium conjugation to a TRAP1 inhibitor, 2-amino-6-chloro-7,9-dihydro-8H-purin-8-one increases antiproliferative activity.

  2022cites this paper
• Lupeol synergizes with doxorubicin to induce anti-proliferative and apoptotic effects on breast cancer cells

  2022cites this paper
• China’s Public Diplomacy Goes Political

  2021cites this paper
• The Mitochondrial Chaperone TRAP1 as a Candidate Target of Oncotherapy

  2021cites this paper
• The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis

  2021cites this paper
• Interleukin-32θ Triggers Cellular Senescence and Reduces Sensitivity to Doxorubicin-Mediated Cytotoxicity in MDA-MB-231 Cells

  2021cites this paper
• Failure to Guard: Mitochondrial Protein Quality Control in Cancer

  2021cites this paper
• Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells

  2021cites this paper
• Mitoquinone Inactivates Mitochondrial Chaperone TRAP1 by Blocking the Client Binding Site.

  2021cites this paper
• Hyaluronic Acid-Conjugated Carbon Nanomaterials for Enhanced Tumour Targeting Ability

  2021cites this paper
• Computational Approaches for the Design of Novel Anticancer Compounds Based on Pyrazolo[3,4-d]pyrimidine Derivatives as TRAP1 Inhibitor

  2021cites this paper
• Mitochondria as playmakers of apoptosis, autophagy and senescence.

  2020cites this paper
• Differential modulation of the androgen receptor for prostate cancer therapy depends on the DNA response element

  2020cites this paper
• Novel therapeutic targets for cancer metastasis

  2020cites this paper
• Computational Approaches for the Designing of Novel Anticancer Compounds Based on Pyrazolo[3,4-d]pyrimidine Derivatives as TRAP1 Inhibitor

  2020cites this paper
• Hsp90 Inhibitor; NVP-AUY922 in Combination with Doxorubicin Induces Apoptosis and Downregulates VEGF in MCF-7 Breast Cancer Cell Line

  2020cites this paper
• Building a circular RNA centered gene regulation network associated with cervical squamous cell carcinoma.

  2020cites this paper
• Cellular Senescence in Aging Mucosal Tissues Is Accentuated by Periodontitis

  2020cites this paper
• Formulation of Stattic as STAT3 inhibitor in nanostructured lipid carriers (NLCs) enhances efficacy of doxorubicin in melanoma cancer cells

  2020cites this paper
• Development of pyrazolo[3,4-d]pyrimidine-6-amine-based TRAP1 inhibitors that demonstrate in vivo anticancer activity in mouse xenograft models.

  2020cites this paper
• Emerging Therapies in Periodontics

  2020cites this paper
• New insights into molecular chaperone TRAP1 as a feasible target for future cancer treatments.

  2020cites this paper
• Interplay between TRAP1 and Sirtuin-3 Modulates Mitochondrial Respiration and Oxidative Stress to Maintain Stemness of Glioma Stem Cells.

  2019cites this paper
• Evaluation OF Potential Cytotoxic Effect of Different Proton Pump Inhibitors on Different Human Cancer Cell Lines.

  2019cites this paper
• HSP90 Inhibitors Blocking Multiple Oncogenic Signaling Pathways for the Treatment of Cancer

  2019cites this paper
• Comparative Study of Antitumor Activity between Lipophilic Bismuth Nanoparticles (BisBAL NPs) and Chlorhexidine on Human Squamous Cell Carcinoma

  2019cites this paper
• Antibiotic Discovery Targeting Bacterial GroEL/GroES Chaperonin Systems

  2018cites this paper
• Synergistic Activation of Doxorubicin against Cancer : A Review

  2018cites this paper
• Hydroxybiphenylamide GroEL/ES Inhibitors Are Potent Antibacterials against Planktonic and Biofilm Forms of Staphylococcus aureus.

  2018cites this paper
• Synergistic Action of 1,2-Epoxy-3 (3- (3,4-dimethoxyphenyl)- 4H-1-benzopiyran-4-on) Propane with Doxorubicin and Cisplatin through Increasing of p53, TIMP-3, and MicroRNA-34a in Cervical Cancer Cell Line (HeLa)

  2018cites this paper
• Activating Transcription Factor 3 as a Novel Regulator of Chemotherapy Response in Breast Cancer12

  2018cites this paper
• p 38 mitogen-activated protein kinase regulates chemoresistance in human gastric cancer via epithelial mesenchymal transition

  2018cites this paper
• Mitochondria in cancer metabolism, an organelle whose time has come?

  2018cites this paper
• TRAP1 Inhibition Increases Glutamine Synthetase Activity in Glutamine Auxotrophic Non-small Cell Lung Cancer Cells.

  2018cites this paper
• Prediction of protein self-interactions using stacked long short-term memory from protein sequences information

  2018cites this paper
• PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy.

  2018cites this paper
• Advances in computational approaches in identifying synergistic drug combinations

  2017cites this paper
• AKR1B10-inhibitory Selaginella tamariscina extract and amentoflavone decrease the growth of A549 human lung cancer cells in vitro and in vivo.

  2017cites this paper
• Coadministration of the FNIII14 Peptide Synergistically Augments the Anti-Cancer Activity of Chemotherapeutic Drugs by Activating Pro-Apoptotic Bim

  2016cites this paper
• The role of VDR and BIM in potentiation of cytarabine–induced cell death in human AML blasts

  2016cites this paper
• Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1.

  2015cites this paper
• Comparison of Immunomodulatory and Anticancer Activities in Different Strains of Tremella fuciformis Berk.

  2015cites this paper